Comment

  • 29 May 2017

    Roundup of Key Oncology Strategic Alliances in Q1 2017

    Strategic alliances between various drug development stakeholders are not usually the largest oncology asset deals recorded, but can provide important clues to the overall strategy and direction of drug development...

  • 23 May 2017

    Pipeline biosimilar surge in emerging markets

    Emerging markets are broadly defined as nations in the process of rapid growth and industrialization. Taking a look in to the trends of the most significant of these markets namely...

Close
Close
Close

Go Top